Heartflow, Inc.

HTFL Healthcare Health Information Services

Heartflow, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $176.0 million, up 39.9% from fiscal 2024.

Revenue
+47.6%
EPS
+87.7%
Free cash flow
+62.6%

Quarter to June 2026, against a year earlier

51.63 0.32 −0.62%
Market cap
$4.5B
P/E
0.0×
Fwd P/E
−72.9×
Dividend yield
—
F-score
5/9
Altman Z
7.22
Beneish M
−2.55
Dividend safety
n/a

Heartflow, Inc. (HTFL) P/E ratio

Alert me on P/E ratio

Heartflow, Inc. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 0.0× (November 2026) — the current reading is the highest in ten years.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2025 0.0× —
FY2024 0.0× —
FY2023 0.0× —

Quarterly newest first

Period P/E ratio Change
Jun 2026 0.0× —
Mar 2026 0.0× —
Dec 2025 0.0× —
Sep 2025 0.0× —
6 more quarters

Against its own ten years

Low 0.0× High 0.0×
Ten-year median 0.0×
Current reading's percentile 100

P/E ratio against peers

Company P/E ratio
HTFL Heartflow, Inc. n/m
SDGR Schrodinger, Inc. compare n/m
TDOC Teladoc Health, Inc. compare n/m
HQY HealthEquity, Inc. compare 36.9×
OMCL Omnicell, Inc. compare 39.0×
WAY Waystar Holding Corp. compare 40.9×
DOCS Doximity, Inc. compare 44.4×
HNGE Hinge Health Inc. compare 86.1×
PRVA Privia Health Group, Inc. compare 88.3×
Health Information Services industry median 42.0×
Healthcare sector median 25.2×
Market median 17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on HTFL